Kamada KMDA
NASDAQ KMDA
$7.69 +0.46 (+6.36%)
At close: Nov 9, 2026 · 4:00 PM EST

Kamada (KMDA) Return on Assets [ROA] (2018 - 2026)

Updated

Kamada (KMDA) posted Return on Assets [ROA] of 5.81% for the quarter ended Jun 30, 2026, up 0.69 percentage points from 5.12% a year earlier and up 0.46 percentage points from the prior quarter.

Analysis

Kamada (KMDA) Return on Assets [ROA] (2018 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, Kamada's Return on Assets [ROA] came in at 5.38%, up 1.40 percentage points from the prior year.

  • Annual Return on Assets [ROA] has increased for four consecutive years, though with a five-year change of -3.54 percentage points (years ended Dec 2020 to Dec 2025).
  • In prior years, Kamada's Return on Assets [ROA] was 3.98% in the year ended Dec 31, 2024 (+1.53 pp), 2.45% in the year ended Dec 31, 2023 (+3.17 pp), -0.72% in the year ended Dec 31, 2022 (+0.12 pp) and -0.84% in the year ended Dec 31, 2021 (-9.76 pp).
  • The figure for the quarter ended Jun 30, 2026 stands as the highest quarterly Return on Assets [ROA] since the quarter ended Mar 31, 2021.
  • On a year-over-year basis, Return on Assets [ROA] has increased in each of the last 15 quarters, with an average year-over-year change of +1.22 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was the quarter ended Sep 30, 2023, with a gain of 5.19 percentage points; the weakest was the quarter ended Jun 30, 2022, with a drop of 9.49 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was 5.35% (quarter ended Mar 31, 2026), 5.34% (quarter ended Dec 31, 2025) and 5.49% (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 8.08%
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 7.32%
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 1.87%
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 9.36%
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 9.80%
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -7.67%
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 2.00%
10 Kamada 441.57 Mn 150.63 Mn 22.47 Mn 5.81%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.81%
Mar 31, 2026 5.35%
Dec 31, 2025 5.34%
Sep 30, 2025 5.49%
Jun 30, 2025 5.12%
Mar 31, 2025 4.30%
Dec 31, 2024 4.00%
Sep 30, 2024 4.47%
Jun 30, 2024 4.34%
Mar 31, 2024 3.57%
Dec 31, 2023 2.39%
Sep 30, 2023 1.89%
Jun 30, 2023 2.18%
Mar 31, 2023 -1.43%
Dec 31, 2022 -1.44%
Sep 30, 2022 -6.75%
Jun 30, 2022 -3.82%
Mar 31, 2022 -2.17%
Dec 31, 2021 -0.83%
Sep 30, 2021 2.11%
API Access

Kamada Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=KMDA&period=max&api_key=YOUR_API_KEY